It is also possible that CM injected intravascularly in sufficient concentrations to bind to IgE in the circulation or on mast cells with the potential to compete with sensitizing antigens can be considered in the therapy of severe anaphylaxis. This evidence concerns the gene IGHE and anaphylaxis.